Curcumin attenuates beauvericin-induced global DNA methylation alterations in liver and colon cells
- 10 October 2026
- journal article
- Published by Elsevier in Food and Chemical Toxicology
- Vol. 219
Abstract
No abstract availableFunding Information
- Türkiye Bilimsel ve Teknolojik Araştırma Kurumu
This publication has 63 references indexed in Scilit:
- Exploring potential molecular targets and therapeutic efficacy of beauvericin in triple-negative breast cancer cellsComputational Biology and Chemistry, 2024
- How epigenetics impacts on human diseasesEuropean Journal of Internal Medicine, 2023
- Protective role of curcumin on broiler liver by modulating aflatoxin B1-induced DNA methylation and CYPs expressionEcotoxicology and Environmental Safety, 2023
- Role of epigenetics in mycotoxin toxicity: A reviewEnvironmental Toxicology and Pharmacology, 2023
- Tiered testing of micro- and nanoplastics using intestinal in vitro models to support hazard assessmentsEnvironment International, 2022
- Antioxidant activity and electrochemical elucidation of the enigmatic redox behavior of curcumin and its structurally modified analoguesElectrochimica Acta, 2015
- Curcumin causes promoter hypomethylation and increased expression of FANCF gene in SiHa cell lineMolecular and Cellular Biochemistry, 2012
- The Epigenomics of CancerCell, 2007
- Beauvericin induces cytotoxic effects in human acute lymphoblastic leukemia cells through cytochrome c release, caspase 3 activation: the causative role of calciumCancer Letters, 2004
- Epigenetic Properties of Fumonisin B1: Cell Cycle Arrest and DNA Base Modification in C6 Glioma CellsToxicology and Applied Pharmacology, 2000